Contact
Please use this form to send email to PR contact of this press release:
Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)
TO:
Please use this form to send email to PR contact of this press release:
Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)
TO: